Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mirati Therapeutics (MRTX)

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,709,770
  • Shares Outstanding, K 51,623
  • Annual Sales, $ 13,400 K
  • Annual Income, $ -357,940 K
  • 60-Month Beta 1.38
  • Price/Sales 718.17
  • Price/Cash Flow N/A
  • Price/Book 8.49
Trade MRTX with:

Options Overview Details

View History
  • Implied Volatility 69.11%
  • Historical Volatility 47.30%
  • IV Percentile 91%
  • IV Rank 46.45%
  • IV High 97.37% on 09/17/21
  • IV Low 44.60% on 07/09/21
  • Put/Call Vol Ratio 0.02
  • Today's Volume 272
  • Volume Avg (30-Day) 349
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 4,728
  • Open Int (30-Day) 9,348

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -2.86
  • Number of Estimates 8
  • High Estimate -2.22
  • Low Estimate -3.41
  • Prior Year -1.96
  • Growth Rate Est. (year over year) -45.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.53 +18.68%
on 10/07/21
195.99 -4.61%
on 10/25/21
+11.30 (+6.43%)
since 09/27/21
3-Month
131.46 +42.21%
on 08/19/21
195.99 -4.61%
on 10/25/21
+34.69 (+22.78%)
since 07/27/21
52-Week
131.46 +42.21%
on 08/19/21
249.42 -25.05%
on 12/14/20
-22.21 (-10.62%)
since 10/27/20

Most Recent Stories

More News
Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced a non-exclusive clinical collaboration...

MRTX : 186.95 (-0.61%)
Pre-Market Brief: Stocks Set to Slump as Global Bond Yields Soar

Morning Markets Dec S&P 500 futures this morning are down by -0.87%. Soaring global bond yields are weighing on technology stocks today and are dragging stock indexes lower. The 10-year T-note yield...

AAPL : 148.85 (-0.31%)
FB : 312.22 (-1.14%)
MSFT : 323.17 (+4.21%)
TSLA : 1,037.86 (+1.91%)
X : 23.32 (-4.19%)
AAL : 19.03 (-1.86%)
NUE : 108.20 (-2.90%)
CLF : 24.80 (-3.24%)
MRTX : 186.95 (-0.61%)
NDLS : 12.26 (-3.16%)
Mirati Therapeutics to Present New Research From its Innovative Oncology Pipeline at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced new clinical and preclinical research...

MRTX : 186.95 (-0.61%)
Pre-Market Brief: U.S. Stocks to Open Sharply Lower on China Risks

Morning Markets Dec S&P 500 futures this morning are sharply lower by -1.79% at a 1-month low. Concern about contagion from the debt crisis at developer China Evergrande Group is hammering global stock...

JD : 80.86 (-0.76%)
PDD : 92.29 (-0.97%)
BABA : 169.23 (-0.45%)
NTES : 100.35 (+1.47%)
BIDU : 167.75 (-0.64%)
FCX : 37.00 (-4.76%)
CLF : 24.80 (-3.24%)
AA : 45.89 (-7.39%)
X : 23.32 (-4.19%)
TSLA : 1,037.86 (+1.91%)
WYNN : 91.79 (-0.40%)
LVS : 40.30 (+3.25%)
RIOT : 26.59 (-6.50%)
BTBT : 9.66 (-4.64%)
MARA : 50.04 (-5.33%)
MRTX : 186.95 (-0.61%)
BRKS : 110.13 (+0.71%)
VSTM : 2.59 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

See More

Key Turning Points

3rd Resistance Point 195.41
2nd Resistance Point 193.05
1st Resistance Point 190.00
Last Price 186.95
1st Support Level 184.58
2nd Support Level 182.22
3rd Support Level 179.17

See More

52-Week High 249.42
Fibonacci 61.8% 204.36
Fibonacci 50% 190.44
Last Price 186.95
Fibonacci 38.2% 176.52
52-Week Low 131.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar